Nuclear Waste:  U.S. Senate Expected to Approve Yucca Mountain

The U.S. Senate is expected to pass a resolution today supporting Yucca Mountain for the site of the first long-term U.S. nuclear waste repository (see GSN, June 26).

Senator Frank Murkowski (R-Alaska) is expected to offer a motion today to consider a joint resolution that would override Nevada Governor Kenny Guinn’s veto of the site, according to CongressDaily.  The motion is likely to cause a procedural vote, which Republican supporters of Yucca Mountain are expected to win closely, CongressDaily reported.

The Nuclear Waste Policy Act, which designated Yucca Mountain as the sole site for a potential nuclear waste repository, allows 10 hours of Senate debate on the resolution before a vote.  To override Guinn’s veto, both houses of Congress must pass the joint resolution, which the U.S. House of Representatives passed in May (CongressDaily, July 9).

A CongressDaily survey indicated that yesterday 51 senators were in favor of the Yucca Mountain repository plan, 25 were opposed and 23 undecided.

Almost all Senate Republicans have said they are backing the plan, with the only opposition coming from Senators Ben Nighthorse Campbell (R-Colo.) and John Ensign (R-Nev.), according to CongressDaily.  Democrats in the Senate have been more divided, with 23 against the repository and 10 in favor.  Out of the senators still publicly undecided on the issue yesterday, 16 were Democrats and six were Republicans (CongressDaily, July 8).

If the Senate approves the override resolution, the U.S. Energy Department will have 90 days to file a license application with the U.S. Nuclear Regulatory Commission, according to the New York Times.  Many Yucca Mountain supporters, however, have said that Energy will not be able to meet that deadline and that it might take up to two years to file an application.

Once Energy files an application, the commission will probably decide based on rules prepared by the U.S. Environmental Protection Agency, according to the Times (see GSN, April 12).  The state of Nevada and the Natural Resources Defense Council, however, are currently challenging the EPA rules (Mitchell/Wald, New York Times, July 9).

Back to top

Radiological Weapons:  States Debate Accepting Potassium Iodide

Fewer than half of eligible U.S. states have accepted medicine from the federal government to guard against thyroid cancer during a nuclear disaster, USA Today reported today (see GSN, May 24).

The U.S. Nuclear Regulatory Commission announced a program six months ago to provide a two-day supply of potassium iodide pills for people living within 10 miles of a nuclear power plant (see GSN, Feb. 15).  Of the 33 states eligible for the program, 15 have accepted the drug, according to USA Today.

Some states have rejected the program, saying that it might give people a false sense of security or that the two-day supply of the drug is not enough because people must take the drug for 10 to 14 days after exposure to radioactive iodine.  The NRC has said a two-day supply is sufficient to protect people as a supplement to evacuation.

Iowa, one of the states that rejected the NRC offer, did so partly because potassium iodide does not protect against other potential consequences of radiation exposure, such as cancers other than thyroid cancer, Iowa’s Public Health Director Stephen Gleason said.  He also expressed concern about giving the drug to people without checking their medical conditions.

States that have accepted the NRC offer are distributing tablets in different ways.  Florida is storing its pills in secret locations to be distributed if a nuclear disaster occurs.  New Hampshire plans to distribute its pills soon after it completes a plan, and New York’s Westchester and Rockland counties began distribution in June.  Other states that have asked for the pills include Alabama, Arizona, California, Connecticut, Maryland (see GSN, Jan. 14), Massachusetts (see GSN, Jan. 11), New Jersey, North Carolina, Ohio, Pennsylvania and Vermont (Haya El Nasser, USA Today, July 9).

Back to top

About Newswire  |  Contact National Journal  |  Re-Use Guidelines

HOME  |  CONTACT US  |  GET INVOLVED  |  SITE MAP